Weight Loss Drugs Linked to Lower Breast Cancer Risk, New Study Finds
As a physician who has spent over a decade navigating the complexities of internal medicine, I have learned that the most promising medical breakthroughs often emerge from the intersection of metabolic health and oncology. Recently, significant attention has been directed toward the role of weight-loss medications—specifically glucagon-like peptide-1 (GLP-1) receptor agonists—and their potential impact on … Read more
